Gegründet: September 2008
New standard in multiplexed protein quantification.
Biognosys is the leading proteomics company dedicated to the development of products for highly multiplexed protein quantification. Biognosys offers wide range of ready-to-use and customized MRM assay panels in forms of kits enabling multiplexed MRM measurements in any lab (e.g. GLP) equipped with the standard mass spectrometry instruments.
Biognosys’ novel Hyper Reaction Monitoring (HRM) technology allows generating new MRM assay panels with unprecedented efficiency. The integration of two platforms – HRM and MRM – accelerates biomarker and drug target discovery by enabling rapid and smooth transition from qualification to validation phase.
Moreover, by simultaneous measurement and storage of full proteome information in a single digital protein map the HRM technology has the potential to revolutionize health care.
Digital proteome maps generated from just a drop of blood are best suited for monitoring health and preserving information for future advances in diagnostics and treatment.
The mission of Biognosys is to bring its technology from research applications to clinical diagnostics enabling personalized health monitoring and truly personalized medicine.
Milestones / News
- - SwissRe Artikel by Biognosys
- - Transkript Spezial Artikel
- - LEADER Artikel BIO Technopark
- - Biognosys Info and Partners
Biognosys Technologie für die Krebsmedizin der Zukunft
Biognosys im NZZ Equity Biotech Report
|Dieses Profil mit anderen teilen|